Moreover, MHC-II signalling, particularly via HLA-DR, has been implicated in promoting cancer cell migration and invasion by upregulating the expression of integrins and cell adhesion molecules and concurrently activating the JAK/STAT3 and PI3K/AKT pathways 61. Here, AKT1 is linked to cancer.